{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:31Z","timestamp":1793032831530,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2024-02929"],"award-info":[{"award-number":["2024-02929"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019286","name":"Ajman University","doi-asserted-by":"publisher","award":["2022-IDG-MED-1"],"award-info":[{"award-number":["2022-IDG-MED-1"]}],"id":[{"id":"10.13039\/501100019286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019286","name":"Ajman University","doi-asserted-by":"publisher","award":["2023-IRG-MED-3"],"award-info":[{"award-number":["2023-IRG-MED-3"]}],"id":[{"id":"10.13039\/501100019286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100646","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:27:29Z","timestamp":1787326049000},"page":"100646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems"],"prefix":"10.1016","volume":"12","author":[{"given":"Delia","family":"Daniele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaw Myo","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-5706","authenticated-orcid":false,"given":"Osama","family":"Saher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-1518","authenticated-orcid":false,"given":"Ibrahim","family":"El-Serafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100646_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100646_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9081046","article-title":"Novel orthogonally hydrocarbon-modified cell-penetrating peptide nanoparticles mediate efficient delivery of splice-switching antisense oligonucleotides in vitro and in vivo","volume":"9","author":"Bazaz","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijpx.2026.100646_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117872","article-title":"Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides","volume":"184","author":"Biswas","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100646_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100646_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.02.008","article-title":"Delivery of therapeutic oligonucleotides with cell penetrating peptides","volume":"87","author":"Boisguerin","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100646_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100646_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41434-018-0040-9","article-title":"Scaffold-mediated delivery for non-viral mRNA vaccines","volume":"25","author":"Chen","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijpx.2026.100646_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010116","article-title":"Lipophilic peptide dendrimers for delivery of splice-switching oligonucleotides","volume":"13","author":"Daralnakhla","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100646_bb0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1039\/D4PM00065J","article-title":"Structure\u2013activity relationships of DNA nanocarriers based on the amphipathic cell penetrating peptide transportan 10","volume":"1","author":"de Mello","year":"2024","journal-title":"RSC Pharm."},{"key":"10.1016\/j.ijpx.2026.100646_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.addr.2007.09.005","article-title":"Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy","volume":"60","author":"Deshayes","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100646_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","article-title":"Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment","volume":"11","author":"El-Sayed","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2026.100646_bb0060","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/la200227b","article-title":"Zwitteration as an alternative to PEGylation","volume":"27","author":"Estephan","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpx.2026.100646_bb0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2174\/138161210790963832","article-title":"Peptide-based matrices as drug delivery vehicles","volume":"16","author":"Ezzat","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpx.2026.100646_bb0070","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1093\/nar\/gkr072","article-title":"PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation","volume":"39","author":"Ezzat","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100646_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15252\/emmm.201607199","article-title":"Delivery is key: lessons learnt from developing splice-switching antisense therapies","volume":"9","author":"Godfrey","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100646_bb0080","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpx.2026.100646_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061180","article-title":"Oligonucleotide(\u2212)Palladacycle conjugates as splice-correcting agents","volume":"24","author":"Hande","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100646_bb0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.addr.2007.09.003","article-title":"Predicting cell-penetrating peptides","volume":"60","author":"Hansen","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100646_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/polym12020298","article-title":"The importance of Poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100646_bb0100","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ijpx.2026.100646_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/polym17152150","article-title":"Polyethylenimine carriers for drug and gene delivery","volume":"17","author":"Ismail","year":"2025","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100646_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.18","article-title":"Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA","volume":"1","author":"Jarver","year":"2012","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ijpx.2026.100646_bb0115","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100646_bb0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100646_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100646_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2016.06.008","article-title":"Peptides for nucleic acid delivery","volume":"106","author":"Lehto","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100646_bb0135","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1038\/s41596-024-01134-4","article-title":"mRNA lipid nanoparticle formulation, characterization and evaluation","volume":"20","author":"Ma","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpx.2026.100646_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2008.11.025","article-title":"A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy","volume":"134","author":"Mae","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100646_bb0145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.addr.2013.04.013","article-title":"Insights into cell entry and intracellular trafficking of peptide and protein drugs provided by electron microscopy","volume":"65","author":"Margus","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100646_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100646_bb0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100646_bb0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10717544.2014.882469","article-title":"A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery","volume":"22","author":"Paliwal","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100646_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1219761","article-title":"PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in vivo","volume":"14","author":"Periyasamy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100646_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2806-4_1","article-title":"Classes of cell-penetrating peptides","volume":"1324","author":"Pooga","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpx.2026.100646_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860290007487","article-title":"Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency","volume":"10","author":"Ramsay","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpx.2026.100646_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100646_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejpb.2018.09.002","article-title":"Novel peptide-dendrimer\/lipid\/oligonucleotide ternary complexes for efficient cellular uptake and improved splice-switching activity","volume":"132","author":"Saher","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100646_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11120666","article-title":"Sugar and polymer excipients enhance uptake and splice-switching activity of peptide-dendrimer\/lipid\/oligonucleotide formulations","volume":"11","author":"Saher","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100646_bb0195","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100646_bb0200","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1016\/j.biomaterials.2010.05.043","article-title":"Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery","volume":"31","author":"Schafer","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100646_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Schottler","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100646_bb0210","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic oligonucleotides: state of the art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpx.2026.100646_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100646_bb0220","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jconrel.2024.07.055","article-title":"NMR-based analysis of impact of siRNA mixing conditions on internal structure of siRNA-loaded LNP","volume":"373","author":"Ueda","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100646_bb0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100646_bb0230","first-page":"1053","article-title":"Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle","volume":"5","author":"Yang","year":"2020","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijpx.2026.100646_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122682","article-title":"Recent advances in lipid nanoparticles for delivery of mRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100646_bb0240","article-title":"Polymer-based mRNA delivery strategies for advanced therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100646_bb0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0005-2760(97)00169-0","article-title":"Effect of serum components on the physico-chemical properties of cationic lipid\/oligonucleotide complexes and on their interactions with cells","volume":"1390","author":"Zelphati","year":"1998","journal-title":"Biochim. Biophys. Acta"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:08:33Z","timestamp":1793030913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S2590156726001660"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100646","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100646"}}